GcMAF is a protein that binds to and activates macrophages, which are white blood cells that kill cancer cells. Researchers have been looking into using GcMAF to treat cancer and other diseases.
The MHRA inspected the production site in Guernsey and found that they were selling GcMAF without a licence. People should be wary of buying this product online as it could be dangerous. Find out more at Gcmaf capsules.
What is Gcmaf?
GcMAF is a naturally occurring glycoprotein in the body that activates macrophages to fight cancer and other pathogens. It also generates superoxide free radicals that have antiangiogenic properties and inhibits tumour growth. GcMAF can be administered externally to increase the effectiveness of immunotherapies such as chemo or radiotherapy and may be useful in treating a number of diseases, including autism, multiple sclerosis, chronic fatigue syndrome and liver cirrhosis.
The MHRA has commenced an investigation into the manufacture of a GcMAF product sold on social media sites under the brand name ‘First Immune’, which is claimed to treat a range of conditions, including autism and HIV. The MHRA has advised people not to buy this product as it does not meet the UK’s medicine safety and quality standards, and it has not been tested for sterility or infection control. It is also illegal to sell unlicensed medicines in or from the Bailiwick of Guernsey, external link.
How is Gcmaf made?
GcMAF is made from the precursor protein Gc protein, also called vitamin D-binding protein. GcMAF is a molecule that activates macrophages, a type of white blood cell that engulfs and digests cellular debris and pathogens. GcMAF stimulates the maturation of dendritic cells and increases the production of superoxide radicals, which kill cancerous cells.
GcMaf is produced in our specialized Saisei Mirai facility under aseptic conditions and sterile filtration. It has been shown to be safe for oral administration and is stable at room temperature for up to a year. Oral GcMAF has been shown to be effective for treating a variety of diseases, including HIV, multiple sclerosis and cancer.
However, MHRA has raised concerns about the production and sale of GcMAF from Guernsey as it does not meet UK Medicines Act requirements and may be contaminated. The MHRA advised anyone buying the product to seek professional medical advice.
What are the side effects of Gcmaf?
GcMAF stimulants increase the amount of GcMAF in the body, increasing the activation of macrophages and boosting the immune system. These stimulants can be administered in a number of ways, including injections, nasal sprays, or oral supplements. The method of administration depends on the health condition being treated.
For cancer treatment, High-Dose GcMAF is usually given via injection, IM or subcutaneously, 1-2 times per week. A minimum treatment course of 6 months is recommended. Further courses may be required based on positive progress and to reduce recurrence.
In Chronic Fatigue Syndrome (CFS) and Myalgic Encephalomyelitis (ME), Low-Dose GcMAF is often used, which is given orally and under the tongue. Low-Dose GcMAF can be obtained from bovine colostrum. It is safe for long-term use and has been shown to be stable with good macrophage phagocytic activity in the lab. This form is called oral GcMAF and is a good alternative to GcMAF injections.
Are Gcmaf capsules safe?
Although GcMAF isn’t an approved treatment for cancer, it has been sold as a supplement online to people with various health problems. It’s important to remember that this product is unlicensed and may pose a significant risk to people who buy it. The MHRA has advised people who have taken GcMAF to seek professional medical advice. In the UK, it is illegal to sell unlicensed medicines from outside of a licensed pharmacy. The BBC’s undercover reporter contacted a company in Guernsey who offered to supply GcMAF to him, and he accepted payment for it. The product was supplied and found to be unstable at room temperature, but the seller claimed it could be refrigerated to maintain activity.